aflibercept 2mg

DRUG3 trials

Sponsors

Vista Klinik, Oxurion, Regeneron Pharmaceuticals

Conditions

Diabetes MellitusDiabetic Macular EdemaDiabetic RetinopathyNeovascular Age-related Macular DegenerationRetinal Vasculitis

Phase 2

A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

CompletedNCT04527107

OxurionDiabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy

Start: 2020-07-31End: 2023-11-22Updated: 2023-11-27

Phase 4

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

CompletedNCT02309281

Vista KlinikNeovascular Age-related Macular Degeneration

Start: 2013-05-31End: 2014-07-31Updated: 2018-10-16

Unknown Phase

Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study

CompletedNCT07105228

Regeneron PharmaceuticalsRetinal Vasculitis

Start: 2025-07-15End: 2025-09-15Updated: 2025-10-10